Incyte Corporation is trading 4.4% up at $105.72 on momentum and dip-buying as the stock extends a three-day recovery from levels below $93.
- The move appears to be driven by technical strength, as no company-specific announcements or earnings catalysts are currently visible in the news flow.
- Incyte is significantly outperforming the broader market, with the S&P 500 down 1.04% and the Nasdaq down 1.84%.